

In a statement to Variety, the company insisted “No Time to Die” didn’t just break even but was a money maker. MGM, the studio behind Bond’s latest adventure, disputes this math. Other industry sources suggest the losses wouldn’t quite reach the nine-figure mark though they would still be substantial. As a result, the film now stands to lose $100 million in its theatrical run, according to sources close to production. Insiders say “No Time to Die” needs to make closer to $900 million to break even, a feat that would have been realistic had a global health crisis not entirely upended the theater industry. However, the movie cost more than $250 million to produce, at least $100 million to promote and tens of millions more to postpone over 16 months. The action-packed spy spectacle, which endured several coronavirus-related delays, has become the rare pandemic-era box office hit, which is even more impressive considering adult audiences - the core demographic for “No Time to Die” - have been reluctant to return to theaters. Over the weekend, “ No Time to Die” eclipsed $730 million in global ticket sales, making the James Bond sequel both the year’s highest-grossing Hollywood film and the top performing film at the box office since COVID-19 appeared on the scene and nearly shut down the movie business.
